Beijing Gene Key Life Technology Co., Ltd
5 clinical trials · Sponsor
◉ Watch Beijing Gene Key Life Technology Co., Ltd
| Record | Firm | Date |
|---|---|---|
| GKL-006Allo Injection in Patients With Advanced Solid Tumors (NCT07704515) | Beijing Gene Key Life Technology Co., Ltd | 2026-08-30 |
| Safety and Efficacy Study of GKL-006RTU in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) (NCT07706855) | Beijing Gene Key Life Technology Co., Ltd | 2026-07-10 |
| GKL-006 Injection Plus TACE Versus TACE Alone in Patients With Unresectable Hepatocellular Carcinoma (NCT07209813) | Beijing Gene Key Life Technology Co., Ltd | 2025-11-14 |
| A Phase I/IIa Study of GKL-006 Injection in Patients With Advanced Pancreatic Cancer (NCT07777211) | Beijing Gene Key Life Technology Co., Ltd | 2025-08-14 |
| A Phase 1b Study of GKL-006 Injection in Patients With Unresectable Hepatocellular Carcinoma (NCT07713290) | Beijing Gene Key Life Technology Co., Ltd | 2025-04-03 |
Track Beijing Gene Key Life Technology Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.